[
    [
        {
            "time": "",
            "orginal_text": "苑东生物「格隆溴铵注射液」第2家获批 视同通过一致性评价",
            "features": {
                "keywords": [
                    "苑东生物",
                    "格隆溴铵注射液",
                    "一致性评价"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "苑东生物「格隆溴铵注射液」第2家获批 视同通过一致性评价",
            "scores": {
                "News_content": "苑东生物「格隆溴铵注射液」第2家获批 视同通过一致性评价",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "先声药业破发疑云 如何抓住重塑窗口？ 连续下跌",
            "features": {
                "keywords": [
                    "先声药业",
                    "破发",
                    "连续下跌"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "先声药业破发疑云 如何抓住重塑窗口？ 连续下跌",
            "scores": {
                "News_content": "先声药业破发疑云 如何抓住重塑窗口？ 连续下跌",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "研发日报丨恩格列净新适应症在中国递交上市申请",
            "features": {
                "keywords": [
                    "恩格列净",
                    "新适应症",
                    "上市申请"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "研发日报丨恩格列净新适应症在中国递交上市申请",
            "scores": {
                "News_content": "研发日报丨恩格列净新适应症在中国递交上市申请",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "32股主力资金净流入超亿元",
            "features": {
                "keywords": [
                    "主力资金",
                    "净流入",
                    "超亿元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "32股主力资金净流入超亿元",
            "scores": {
                "News_content": "32股主力资金净流入超亿元",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "Q3净亏损同比扩大38%，百济神州的营收增长是个“伪命题”？ 亏损",
            "features": {
                "keywords": [
                    "百济神州",
                    "净亏损",
                    "营收增长",
                    "伪命题"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "Q3净亏损同比扩大38%，百济神州的营收增长是个“伪命题”？ 亏损",
            "scores": {
                "News_content": "Q3净亏损同比扩大38%，百济神州的营收增长是个“伪命题”？ 亏损",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "[读财报]10月份重要股东增减持动态：增减持金额环比均降逾八成 减持股份",
            "features": {
                "keywords": [
                    "增减持",
                    "金额下降",
                    "减持股份"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "[读财报]10月份重要股东增减持动态：增减持金额环比均降逾八成 减持股份",
            "scores": {
                "News_content": "[读财报]10月份重要股东增减持动态：增减持金额环比均降逾八成 减持股份",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "莎普爱思大涨5.64%，超跌股有望逐步修复",
            "features": {
                "keywords": [
                    "莎普爱思",
                    "大涨",
                    "超跌股",
                    "修复"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "莎普爱思大涨5.64%，超跌股有望逐步修复",
            "scores": {
                "News_content": "莎普爱思大涨5.64%，超跌股有望逐步修复",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "寻找下一个PD-1/PD-L1之TIGIT篇",
            "features": {
                "keywords": [
                    "PD-1",
                    "PD-L1",
                    "TIGIT"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "寻找下一个PD-1/PD-L1之TIGIT篇",
            "scores": {
                "News_content": "寻找下一个PD-1/PD-L1之TIGIT篇",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "医药恢复高增长，未来跟随政策变化选股——兴证医药2020年11月投资月报",
            "features": {
                "keywords": [
                    "医药",
                    "高增长",
                    "政策变化",
                    "选股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "医药恢复高增长，未来跟随政策变化选股——兴证医药2020年11月投资月报",
            "scores": {
                "News_content": "医药恢复高增长，未来跟随政策变化选股——兴证医药2020年11月投资月报",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "QFII重仓50强来了！23股连续20个季度获持有",
            "features": {
                "keywords": [
                    "QFII",
                    "重仓",
                    "连续持有"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "QFII重仓50强来了！23股连续20个季度获持有",
            "scores": {
                "News_content": "QFII重仓50强来了！23股连续20个季度获持有",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "公募基金股票仓位升至72.47%，增配周期、消费，减仓医药、TMT",
            "features": {
                "keywords": [
                    "公募基金",
                    "股票仓位",
                    "增配",
                    "减仓",
                    "医药"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "公募基金股票仓位升至72.47%，增配周期、消费，减仓医药、TMT",
            "scores": {
                "News_content": "公募基金股票仓位升至72.47%，增配周期、消费，减仓医药、TMT",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "A股融资融券日报：两融余额增加58.37亿元（11月3日）",
            "features": {
                "keywords": [
                    "A股",
                    "融资融券",
                    "两融余额",
                    "增加"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "A股融资融券日报：两融余额增加58.37亿元（11月3日）",
            "scores": {
                "News_content": "A股融资融券日报：两融余额增加58.37亿元（11月3日）",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "海外疫情反复，结合三季度业绩挑选优质标的——医药行业周报——中性",
            "features": {
                "keywords": [
                    "海外疫情",
                    "三季度业绩",
                    "优质标的",
                    "医药行业"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "海外疫情反复，结合三季度业绩挑选优质标的——医药行业周报——中性",
            "scores": {
                "News_content": "海外疫情反复，结合三季度业绩挑选优质标的——医药行业周报——中性",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "2020深圳BT峰会18日举行 专家将聚焦“深圳生物技术的下一个五年”",
            "features": {
                "keywords": [
                    "深圳BT峰会",
                    "生物技术",
                    "下一个五年"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "2020深圳BT峰会18日举行 专家将聚焦“深圳生物技术的下一个五年”",
            "scores": {
                "News_content": "2020深圳BT峰会18日举行 专家将聚焦“深圳生物技术的下一个五年”",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "QFII持仓市值突破2000亿 23股获连续20个季度持有",
            "features": {
                "keywords": [
                    "QFII",
                    "持仓市值",
                    "连续持有"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "QFII持仓市值突破2000亿 23股获连续20个季度持有",
            "scores": {
                "News_content": "QFII持仓市值突破2000亿 23股获连续20个季度持有",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "最牛百亿级爆款基金收益率达85% 医药主题却黯然失色",
            "features": {
                "keywords": [
                    "百亿级基金",
                    "收益率",
                    "医药主题",
                    "黯然失色"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "最牛百亿级爆款基金收益率达85% 医药主题却黯然失色",
            "scores": {
                "News_content": "最牛百亿级爆款基金收益率达85% 医药主题却黯然失色",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]